ubenimex has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Abe, S; Aoyagi, K; Ikeda, T; Ishizuka, M; Ito, N; Takeuchi, T; Uchida, K; Yamaguchi, H | 1 |
| Abe, F; Abe, S; Aoyagi, K; Ishizuka, M; Itoh, N; Takeuchi, T; Uchida, K; Yamaguchi, H | 1 |
2 other study(ies) available for ubenimex and Candidiasis
| Article | Year |
|---|---|
Enhancement of host resistance to opportunistic infections by ubenimex (bestatin).
Topics: Animals; Candidiasis; Female; Immunocompromised Host; Immunologic Factors; Leucine; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Neutrophils; Opportunistic Infections; Phagocytosis | 1992 |
Enhancement by ubenimex (bestatin) of host resistance to Candida albicans infection.
Topics: Animals; Candidiasis; Cyclophosphamide; Female; Immunity, Innate; Immunologic Factors; Immunosuppression Therapy; Leucine; Luminescent Measurements; Male; Mice; Mice, Inbred C3H; Neutrophils; Phagocytosis | 1992 |